Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Final results of the HERACLES trial in HER2-amplified colorectal cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.04.17
Views: 1593

Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy

Dr Silvia Marsoni presents trial data at AACR 2017 from the HERACLES trial, in which patient-derived xenografts were able to guide treatment choices for cetuximab-resistant colorectal cancer.

To view the slides from this presentation, click here.

Dr Marsoni discussed these results further with ecancer here.

Related videos

follow us

NCRI 2018

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation